My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cytosorbents Corporation - Common Stock (NQ:CTSO)

0.5754 -0.0097 (-1.66%)

Streaming Delayed Price Updated: 9:46 AM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytosorbents Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

June 04, 2024

From CytoSorbents

Via GlobeNewswire

CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

CTSO stock results show that CytoSorbents met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

CytoSorbents Reports First Quarter 2024 Results

May 09, 2024

From CytoSorbents

Via GlobeNewswire

Recap: CytoSorbents Q4 Earnings ↗

March 14, 2024

Via Benzinga

A Preview Of CytoSorbents's Earnings ↗

March 13, 2024

Via Benzinga

What To Know About HC Wainwright & Co.'s Downgrade of CytoSorbents ↗

December 29, 2023

Via Benzinga

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

May 02, 2024

From CytoSorbents

Via GlobeNewswire

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

April 26, 2024

From CytoSorbents

Via GlobeNewswire

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

April 17, 2024

From CytoSorbents

Via GlobeNewswire

Recap: CytoSorbents Q3 Earnings ↗

November 09, 2023

Via Benzinga

CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023 ↗

March 14, 2024

CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

March 14, 2024

From CytoSorbents

Via GlobeNewswire

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

March 06, 2024

From CytoSorbents

Via GlobeNewswire

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

February 08, 2024

From CytoSorbents

Via GlobeNewswire

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 17, 2024

Via Benzinga

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

January 17, 2024

CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and Dysfunction

From CytoSorbents

Via GlobeNewswire

CYTOSORBENTS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cytosorbents Corporation on Behalf of Cytosorbents Stockholders and Encourages Investors to Contact the Firm

January 08, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Gold Moves Lower; US Crude Stocks Decline Last Week ↗

December 28, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90....

Via Benzinga

Topics Stocks

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 28, 2023

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 28, 2023

Via Benzinga

Crude Oil Down 1%; US Wholesale Inventories Fall In November ↗

December 28, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The...

Via Benzinga

Topics Stocks

Dow Gains 50 Points; US Jobless Claims Rise To 218,000 ↗

December 28, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.14% to 37,708.72 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Is Blood Purification Focused CytoSorbents Trading Lower Today? ↗

December 28, 2023

CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 28, 2023

Via Benzinga

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

December 28, 2023

From CytoSorbents

Via GlobeNewswire

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

December 13, 2023

Company insiders participated in the transaction with $435,000 of investment

From CytoSorbents

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 17, 2023

Via Benzinga

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

November 09, 2023

Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data...

From CytoSorbents

Via GlobeNewswire

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

October 27, 2023

From CytoSorbents

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.